Human Molecular Genetics Advance Access originally published online on August 4, 2004
Human Molecular Genetics 2004 13(19):2333-2341; doi:10.1093/hmg/ddh240
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 13, No. 19 © Oxford University Press 2004; all rights reserved
The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control


1Section of Molecular Genetics and Infertility, Department of Gynecological Endocrinology and Reproductive Medicine, University of Heidelberg, Heidelberg, Germany and 2Department of Growth and Reproduction, Copenhagen University Hospital (Rigshospitalet) Section GR-5064, Copenhagen, Denmark
Received June 24, 2004; Accepted July 21, 2004
| ABSTRACT |
|---|
|
|
|---|
We explored the function of the human DEAD-box Y RNA helicase DBY (DDX3Y) gene located in the (AZFa) region on the human Y chomosome (Yq11.21). Deletion of this Y interval is known to be a major cause for the occurrence of a severe testicular pathology, the Sertoli-cell-only (SCO) syndrome. DBY has a structural homologue on the short arm of the X chromosome DBX (DDX3X) (Xp11.4). We found widespread transcription of both genes in each tissue analyzed, although predominantly in testis tissue. However, translation of DBY was detected only in the male germ line, whereas DBX protein was expressed in all tissues analyzed. In testis tissue sections, DBY protein was found predominantly in spermatogonia, whereas DBX protein was expressed after meiosis in spermatids. We conclude that although both RNA helicases are structurally very similar, they have diverged functionally to fulfill different roles in the RNA metabolism of human spermatogenesis, and that deletion of the DBY gene is the most likely cause of the severe testicular pathology observed in men with AZFa deletions.
| INTRODUCTION |
|---|
|
|
|---|
The azoospermia factor a (AZFa) deletion interval has been mapped to proximal Yq11 (Yq11.21) (1). It is 792 kb in size and contains two protein-coding Y genes, USP9Y (ubiquitin specific protease 9 Y) and DBY (DEAD-box RNA helicase Y; DDX3Y) (24). Since AZFa deletions are found at high frequency in men with a complete germ cell loss [the Sertoli-cell-only [SCO] syndrome] (5,6), it has been suggested that the AZFa genes are functional during an early phase of human spermatogenesis (7,8). Both AZFa genes have a homologue on the short arm of the X chromosome (Xp11.4), USP9X [DFFRX (9)] and DBX (10); [DDX3 (11); DDX14 (12); DDX3X (13)]. Their high sequence similarity to the Y copies (>94%) throughout the complete coding regions suggests that both genes should have a similar cellular function. Functional replacement of the yeast DED1 RNA helicase with the human DBX gene or its mouse homologue D1Pas1/PL10 (14,15) suggests that DBX proteins, and thus probably also DBY proteins, are required for the initiation of translation. However, a nuclear function is indicated as well, because the lack of DBX proteins in hamster ET24 cells resulted in an arrest of the cellular division cycle at the G1 phase (16).
Although northern blot analysis has shown expression of both AZFa genes in multiple tissues (10), USP9Y and DBY gene mutations were found to be associated only with distinct testicular pathologies; no somatic pathologies were reported. A point mutation at a USP9Y splicing site truncating the protein by
90% was found in one man with spermatid arrest (17), and complete USP9Y deletion resulted in a similiar testicular pathology (18, patient SAYER). DBY deletions were found in men with different testicular pathologies including the SCO syndrome (19). Therefore, it has been proposed that the AZFa genes are functional only in the male germ line and that the complete SCO syndrome observed in the testis tissue of men with a complete AZFa deletion is caused after deletion of both AZFa genes, USP9Y and DBY, or after deletion of only the DBY gene (17,19,20).
The highly homologous X copies, USP9X and DBX, are expected to function during spermatogenesis as well. It is therefore surprising that these are not able to compensate for the loss of USP9Y and DBY function in men with an AZFa deletion. One explanation might be that both AZFa genes form complexes with their X homologues in the male germ line, whereas another might be that the Y copy has a different role in spermatogenesis not provided by the X copy.
We addressed this challenging query first with respect to the DBY and DBX gene pair because DBY deletions were found in men with the most severe testicular pathology (19), and because some homologues of DBY in mouse (D1Pas1/PL10) and frogs (Xan3) were found to be expressed in the male and female germ lines, respectively (2123). Their conserved peptide boxes and overall similarity are distinct from that of the EIF1A (24), P68 (25) and VASA (26) homologues in these species and most comparable with that of the human DBY and DBX proteins. They, therefore, can be designated as the DBY protein subfamily of the highly conserved DEAD-box RNA helicases (27) with comparable molecular weights and a high sequence similarity (
90%) throughout the whole coding sequence, supporting the possibility of a similar germ line function for these RNA helicases in humans as well.
We studied the functions of the DBY and DBX genes in the human male germ line, separately. Their transcriptional profiles were distinguished by gene copy-specific RTPCR analyses, their translational profiles by polyclonal antisera which mark specifically only the DBY- and/or DBX-encoded proteins in western blots and in testicular tissue sections. Our results suggest a translational control for DBY transcripts such that protein is synthesized only in the male germ line. The predominant expression of DBY protein in spermatogonia reveals that deletion of the DBY gene in men with AZFa deletions is the most likely cause of their severe testicular pathology.
| RESULTS |
|---|
|
|
|---|
DBY and DBX are transcribed predominantly in testis tissue
The DBY and DBX genes were first identified from two different cDNA clones each (DBY1, DBY2 and DBX1, DBX2; GenBank accession nos AF000984, AF000985 and AF000982, AF000983, respectively) extracted from a testis cDNA library (10). In this early study, the authors suggested ubiquitous transcription of the DBY gene at similar levels in all the tissues analyzed, although testis-specific shorter DBY transcripts (3 kb) were indicated by their northern blot as well. The DBY hybridization probe used for this northern blot, however, also hybridized strongly with an RNA sample from human ovary, suggesting significant cross-reaction with the homologous DBX transcript (Fig. 2, in 10). The real level of DBY and DBX transcripts in each tissue analyzed could therefore not be determined by this experiment. For that reason, we first repeated the RNA blot experiment using a more specific DBY hybridization probe. With this probe, we detected predominant expression of DBY in testis tissue, where there were at least five different RNA species with lengths of 5.2, 3.9, 3.2, 2.9 and 2.7 kb (Fig. 1A). The 5.2 kb RNA was also found in all other tissues analyzed although at a lower and rather variable level. This DBY RNA blot pattern is thus significantly different from that of the earlier study, demonstrating variable quantities of DBY transcripts in the human tissues analyzed and distinguishing not one but five distinct RNA species in testis tissue by their different transcript lengths.
|
However, this DBY probe also shows weak cross-reaction with DBX transcripts, as indicated by its hybridization to the 5.2 kb RNA population in the ovary RNA sample (Fig. 1A). Thus, we cannot exclude the possibility that some of the other transcripts detected by the DBY probe are derived from the DBX gene.
We therefore used an alternative method to distinguish the transcripts of the DBY and DBX genes: semi-quantitative RTPCR amplification using primer pairs specific for either the DBY or DBX transcript and their comparative analysis on a single agarose gel (Fig. 1B). We found DBY transcripts in all male tissues analyzed and in male leukocytes, but not in female leukocytes, which confirmed the specificity of the DBY primer pairs. DBX transcripts were also found in all male tissues and in male and female leukocytes, but always in a significantly lower quantity than DBY transcripts. The highest level of DBX transcripts was detected in testis tissue. Evaluation of the semi-quantitative expression patterns in the linear range of the fluorescent intensities (Fig. 1C) shows that there are tissue-specific differences in DBY and DBX transcript levels. In each male tissue, more DBY than DBX products were identified by PCR in the same RNA sample.
The antisera DBY-10/DBX-10 detect the individual DBY and DBX proteins specifically
The specificity of our polyclonal DBX and DBY antisera (DBY-10 and DBX-10) for the detection of only DBY or only DBX proteins were shown to be very high by specific peptide blot tests and peptide specific affinity chromatography (see Materials and Methods). Most crucial would be, however, an analysis of their cross-reaction on western blots containing protein extracts from Escherichia coli cells expressing full-length recombinant DBY and DBX proteins (for details see Materials and Methods). The DBY-specific antiserum only detects the recombinant DBY protein, whereas the DBX-specific antiserum only detects the recombinant DBX protein (Fig. 2). In the same kind of experiment, the DBXY-20 antiserum prepared with a specific peptide of DBY and DBX (see Materials and Methods) was able to detect both DBX and DBY proteins (data not shown). The three polyclonal antisera, DBY-10, DBX-10 and DBXY-20, should therefore also be able to distinguish DBY and DBX proteins on western blots of protein extracts from human tissues.
|
DBY proteins are only detectable in human testis tissue
We prepared cellular protein extracts from clinical biopsies of human male brain, kidney and testis tissue, and from female ovary tissue, for the analysis of DBY and DBX proteins. After fractionation on polyacrylamide gels they were blotted onto nylon filters and incubated with DBY- and DBX-specific antisera (Fig. 3A). No cross-reaction with the DBY-10 antiserum was observed with the ovary protein sample, as expected, but surprisingly the male brain and kidney protein extracts did not display any cross-reaction either. A distinct cross-reaction with the DBY-10 antiserum to a single protein band was only found in the protein extract from the testis tissue (Fig. 3A). Its molecular weight of 73 kDa corresponds to the expected size of the DBY protein. We did not find cross-reaction to the other male tissues even when we extended the detection time or used the most sensitive kit available (SuperSignal® West Femto; Pierce, Bonn, Germany). When we pre-incubated the DBY-10 antiserum with its parental DBY-10 peptide or the recombinant DBY protein, cross-reaction to the testis protein was abolished as well. We therefore conclude that the testis protein detected by the DBY-10 antiserum is indeed the DBY protein and that this protein is expressed only in testis tissue.
|
When we incubated the same western blotafter strippingwith the DBX-10 antiserum, a protein with a similar size (73 kDa) was detected in each tissue analyzed (Fig. 3A). We found no cross-reaction on this western blot with the pre-immune serum of the rabbits used in the DBY-10 and DBX-10 immunization protocol. When we incubated the DBXY-20 antiserum with this western blot, the same staining pattern as seen with the DBX-10 antiserum was found (data not shown). The protein of 73 kDa marked with the DBX-10 antiserum should therefore represent the DBX protein expressed in human male brain, kidney and testis tissue, and in the female ovary.
DBY and DBX proteins are expressed in germ cells of different spermatogenic phases
On the basis of the specificity of the DBY-10 and DBX-10 antisera (Fig. 2), we could now explore the expression of DBY and DBX separately in tissue sections from the human testis. The DBY-specific antiserum, DBY-10, stained predominantly the cytoplasm of spermatogonia suggesting a cytoplasmic function for DBY proteins in these germ cells (Fig. 3B). Occasionally, a prominent staining of the cytoplasm of some pre-leptotene/leptotene spermatocytes was observed as well. The DBX-specific antiserum, DBX-10, also stained germ cells but of a different spermatogenic phase, after meiosis: namely spermatids. To exclude the possibility that these pictures are non-specific cross-reactions, we confirmed our basic result by incubating some sections of the same testicular tissue with (1) the DBXY-20 antiserum which is expected to mark both proteins and (2) the pre-immune sera of the rabbits used for preparation of both antisera. No cross-reaction was obtained with the pre-immune sera, but the DBXY-20 staining picture seemed to combine the location of the DBY and DBX proteins staining the cytoplasm of spermatogonia and spermatids (Fig. 3B). The same pattern of DBY and DBX protein expression was also found with other testicular specimens with complete spermatogenesis. Our results therefore strongly suggest that the DBY and DBX RNA helicases, despite their high sequence homology, have a different function in the developmental sequence of the human male germ line. Whereas DBY protein function is contributing mainly to the premeiotic spermatogonia phase, DBX proteins are functioning after meiosis in spermatids.
| DISCUSSION |
|---|
|
|
|---|
RNA helicases of the DEAD (Asp-Glu-Ala-Asp) box family have an ancient origin. They are found in almost all organisms and are associated with many processes in the life of an RNA molecule, ranging from synthesis to degradation (27). They rearrange inter- or intra-molecular RNA structures or RNAprotein complexes and all contain the same structurally conserved core element characterized by seven peptide domains conserved from yeast to human (27). This core element is flanked by divergent amino- and carboxy-terminal sequences determining the specific function of each RNA helicase and allowing the designation of distinct subfamilies.
In this paper, we present strong experimental evidence that the human DBX and DBY DEAD-box RNA helicases, although structurally very similar (>95%) along the complete length, are functionally expressed at two different phases of the male germ line (Fig. 3B). Moreover, although both genes are transcribed in all tissues analyzed and in leukocytes, the DBY protein was observed only in testis tissue, whereas the DBX protein was found in male brain and kidney as well as in female ovary tissue. These results support the suggestion of Skaletsky et al. (28) who grouped the DBY gene with the X-degenerate Y gene class with a likely widespread function of the ancient X gene copy but a male-specific function of the Y gene copy.
Structural homologues of the human DBY and DBX genes in mouse [Dby/Dbx (29); PL10/D1Pas1 (21,22)], in frog [Xan3 (23)] and in zebrafish [ZfPl10a (30)] are also functionally involved in the male and female germ lines. The DBY DEAD-box subfamily is therefore reminiscent to the Vasa DEAD-box subfamily with a similar conserved germ line function (31). However, whereas the location of VASA proteins in fetal and adult germ cells seems to be conserved from Drosophila to human (31) the location of proteins encoded from the DBY family in the male germ line seems to be distinct in mouse and human. Thus there is yet no evidence for a requirement of the mouse Dby gene at any stage of the mouse male germ line (32), whereas in human, DBY deletions cause a severe testicular pathology (19) and accordingly DBY proteins were found predominantly in spermatogonia (Fig. 3B). The mouse homologues, Dby and Dbx, are located in the Sxrb interval of the short Y arm (Dby) and X arm (Dbx), respectively, and their transcription products were found in multiple tissues (29), whereas an autosomal retrogene of Dbx (PL10/D1Pas1 on chromosome 1; 101.5 cM) is expressed only in testis tissue (21,22).
The creation of intron-less retrogenes from their progenitor genes by retroposition of their transcripts seems to be a common mechanism for male germ line genes when they are located on the X chromosome and have a function at meiosis (33). Indeed, D1Pas1 protein is expressed predominantly in the nuclei of germ cells undergoing meiosis (22), where transcription of the mouse Dby and Dbx genes is repressed because of the meiotic sex chromosome inactivation (MSCI) and formation of the sex vesicle (34). A similiar autosomal functional retrogene for the human DBY gene was not found (35). One may therefore assume that in human this back-up is not necessary because the DBY protein expressed until leptotene (see Fig. 3B) is stable enough to last also through the long and metabolically very active stage of the meiotic pachytene. Another possibility might be that in humans a functionally similiar DEAD-box RNA helicase is replacing or complementing the DBY helicase function in the pachytene germ cells. Putative candidates are the VASA protein most abundantly expressed in spermatocytes (31) and the EIF2
A protein encoded from the autosomal retrogene EIF2
A (on 12p13.212.3) of the X chromosomal EIF2
X locus located in Xp22.122.2 (36). In contrast to its parental X gene copy, EIF2
A is expressed only in testis tissue. It has retained his ORF and is 97.5% homologous to the EIF2
X gene sequence. If this retrogene encodes a functional EIF2
A protein it is most likely required for the testis specific initiation of translation processes similar to we could show for the DBY DEAD RNA helicase in this paper (Fig. 3). Unfortunately, the location of the EIF2
protein in the human male germ line is not yet known, but it might be interesting to recall in this context the germ line function of the EIF2
mouse homologue, Eif2-s3y, which is required for normal spermatogonial proliferation and progression of the mouse male germ cells through the meiotic prophase (32).
From the viewpoint of evolution, the Sxrb interval on the short arm of the mouse Y chromosome has been considered to be functionally equivalent to the human AZFa interval, because after Sxrb deletion spermatogonia proliferation is disrupted in the mouse male germ line as was found after AZFa deletion in human. The associated functional mouse gene locus was therefore called spermatogonia proliferation y (Spy) locus (37). Indeed, the gene content of both spermatogenesis loci, Spy and AZFa, seemed to be comparable: both contain the syntenic triplets, Usp9y, Dby and Uty (homologues to UTY in proximal Yq11 adjacent to the AZFa deletion interval), which are structurally also conserved on the Y chromosome of cats and pigs (38,39). However, other Y genes which were also mapped to the mouse Spy locus, Eif2s3y, Smcy, Ube1y, Zfy, were not found in the human AZFa locus, suggesting that the functional conservation of both spermatogenesis loci might be limited. Accordingly, expression of the Eif2s3y transgene and not that of the Dby transgene was able to restore normal spermatogonial proliferation in mouse strains with Spy deletion (32). The evolutionary pressure on Y genes functional for spermatogenesis in mouse and humans seems therefore to be different on the scale of a single gene and more comparable if setting the focus on the spermatogenic functions of the complete Y gene content of the Spy and AZFa loci, both involved in the same genetic network controlling the proliferation of spermatogonia. If this holds true, the mouse Eif2s3y gene might then perhaps be considered as the functional equivalent of the human DBY gene and probably also vice versa, as discussed already in the last paragraph.
The presence of the DBY protein only in human testis tissue and its predominant location in spermatogonia suggests that it contributes to the function of human spermatogonia and that this function is essential because its deletion in men with AZFa or DBY deletions results in a severe testicular pathology including the SCO syndrome (1,19). An intriguing speculation in this context might be the assumption of some functional interactions between DBY and DBX transcripts (or proteins) in the male germ line constituting a haplo-insufficient genotype and genetic dominance of the DBY locus similar as proposed by Wilkie (40). This would also help to explain the variability of the testicular pathologies observed in some men with DBY deletions (19). Indeed, there is a higher level of DBY transcripts than DBX transcripts in all tissues analyzed and especially in testis tissue where only DBY and not DBX transcripts are prominent (Fig. 1). Accordingly, we would expect a different transcription profile for the DBX gene in men with DBY deletions. It is also possible, however, that the variability of the testicular pathologies in men with DBY deletions could be due to a primarily postmeiotic spermatogenic disruption after DBY deletion, and that the SCO syndrome is due to secondary age-dependent effects, like those described for patients with AZFc deletions (7,41). The SCO syndrome as a secondary age-dependent effect was also described in two mice strains (X0Sry/Eif2s3y and XSxrb0/Eif2s3y) which both lack Dby, the DBY mouse homologue (32).
| MATERIALS AND METHODS |
|---|
|
|
|---|
RNA analysis
Two human multiple tissue northern blots MTN-I and II (Clontech, Heidelberg, Germany) were hybridized with a 32P-labelled PCR product generated from the 3' end of DBY cDNA (forward primer: 5'-GCTGATAGGATGCTGGATATGG-3'; reverse primer: 5'-TGCTTCCGCGACTAGCACC-3'). Sequences and PCR-conditions are deposited in the GenBank STS database (accession no. BV208342). Pre-hybridization and hybridization were carried out in 5 ml of ExpressHybTM solution according to the manufacturer's instruction. A 32P-labelled PCR product of the ß-actin gene (GenBank accession no. NM_001101; forward primer: 5'-ATCCTGCGTCTGGACCTG-3'; reverse primer: 5'-GCTGATCCACATCTGCTG-3') expressed in each tissue was used as an internal control probe.
A semi-quantitative RTPCR method (42) was performed to measure the levels of DBY and DBX mRNA separately with DBY- and DBX-specific primer pairs. The DBY primers are described above, the DBX specific forward primer (5'-GAAGCTACTAGAGGTTTCTAC-3') and reverse primer (5'-TCTCAACATCACTGAAACTTTC-3') amplify a cDNA sequence of 422 nt between exon 3 and exon 7 only of DBX (GenBank accession no. BV208341). All cDNAPCR reactions were carried out in a T96-Gradient cycler (Biometra, Goettingen, Germany). For the RNA extractions from the tissues indicated we used the RNeasy Mini Kit (Qiagen, Hilden, Germany) and followed the manufacturer's protocol. RTPCR reactions were performed with
40 ng oligo-dT primed cDNA, according to the following conditions: denaturation at 94°C for 45 s, annealing at 60°C (for DBX) and 62°C (for DBY) for 45 s and extension at 72°C for 45 s. After the chosen number PCR cycles (1040), the corresponding PCR reaction was extended at 72°C for 5 min, cooled in ice-water and stopped with 0.5 M EDTA buffer. An amount of 4 µl of each reaction mix was run on a 1% agarose gel and quantitatively evaluated after staining with ethidium bromide and visualization on an UV transilluminator. Image analysis was performed with the Gel DocTM 2000 IMAGER system and the Quantity One 1-D software (BIO-RAD, Munich, Germay).
| PROTEIN ANALYSIS |
|---|
|
|
|---|
Preparation of polyclonal antisera
The DBY and DBX proteins belong to the highly conserved DEAD box family of RNA helicases which has multiple members also in the human genome (13). Screening the GenBank/SWISSPROT/TREMBL database for human DEAD-box RNA helicases with a significant similarity to the DBY and DBX protein sequences only the proteins derived from the DDX3 (GenBank accession no. AF061337) and DDX14 (GenBank accession no. U50553) genes were identified. Both genes seem to be identical to DBX because they had the same sequences, encode the same number of amino acids (662 aa) and mapped on the same site on the X chromosome (Xp11.4). For the preparation of specific DBY and DBX antisera in rabbits, we therefore selected synthetic peptides from the N-terminal region of the DBY (DBY-10: VVKNDPELDQ) and DBX (DBX-10: AVENALGLDQ) protein. These were synthesized by Peptide Speciality Laboratories GmbH (Heidelberg, Germany). We also prepared a polyclonal antiserum from a peptide sequence which is only found in proteins of the DBY subfamily (DBXY-20: ASTASKGRYIPPHLRNKEAS). Purified peptides were conjugated to a carrier protein (maleimide-activated keyhole limpet hemocyanin; KLH; 1 mg peptide/1 mg KLH) via their C-terminal cysteine residue using the Imject Activated Immunogen Conjugation Kit (Pierce, Bonn, Germany) and subcutaneously injected into New Zealand White rabbits following a standard booster protocol. Specificity and titre of the antisera were controlled by hybridization to ovalbumin coupled parental peptides spotted at different concentrations onto nitrocellulose membrane stripes (Sartorius, Goettingen, Germany). The DBY-10 antiserum detected only the parental DBY peptide and the DBX-10 antiserum only the DBX peptide. Positively reacting antisera were enriched from the crude blood serum by ammonium sulphate precipitation and purified by affinity chromatography (SulfoLink Coupling Gel Support resin; Pierce). All fractions containing a positive cross-reaction to only their parental peptide were brought to neutral pH conditions with 1 M Tris buffer (pH 8) and stored in siliconized tubes with 50% glycerol at 80°C.
Preparation of DBY and DBX His-tagged recombinants expressed in M15 [pREP4] cells
His-tagged fused DBX and DBY full-length recombinants were constructed by cloning in-frame the full-length cDNA products of both genes in the BamHI and SalI cloning sites of the pQE80L expression vector (The QIAexpressionistTM; Qiagen). Expression of the full-length His-tagged-DBY and DBX recombinants in M15 (pREP4) cells was induced with 1 mM IPTG (0, 30 and 60 min) and increasing quantities detected on western blots after incubation with Tetra-His antiserum (Qiagen). Two clones with the highest expression titre (DBYfl-K13 and DBXfl-K68) were preserved with 15% glycerol at 80°C. For the competition assays large quantities of the DBY and DBX recombinants were prepared in 200 ml LB medium after growing of the cells to OD600
0.70.9 and 30 min induction with 1 mM IPTG. The recombinant proteins were purified after sonication (5 s bursts with microtip) by His-Tag affinity chromatography using a imidazol gradient between 0.1 and 0.5 M. Fractions of the pure protein were collected and stored at 80°C.
Western blots
The protein extracts from frozen tissue samples were homogenized on ice using standard protocols. Aliquots of 30 µg were loaded onto a 12% SDSpolyacrylamide gel for their size fractionation. Sample blocks (brain, kidney, ovary and testes) were stained with 0.2% Serva Blue R250 (Serva, Heidelberg, Germany), or electrophoretically transferred onto an Immobilon-P membrane (Millipore, Eschborn, Germany). After pre-incubation of the membranes in blocking solution [5% skimmed milk powder in 1x TNT (50 mM Tris, 150 mM NaCl, 5 mM EDTA and 0.05% Tween 20; pH 7.6)] for 30 min at room temperature, they were incubated with the affinity-purified antisera (1 : 100 v/v) for 1.5 h. For the competition experiments, both antisera were pre-incubated with different concentrations of the parental peptides, DBY-10 or DBX-10, or the purified recombinant DBY and DBX proteins, respectively. Visualization of the hybridization pattern was achieved by incubation with an anti-rabbit IgG-peroxidase conjugate (1 : 30.000 v/v) as the secondary antibody (Dianova, Hamburg, Germany) in the same blocking solution for 30 min and the Western Lightning Chemiluminescence Reagent Plus kit (Perkin Elmer, Langen, Germany) according to the manufacturer's instructions.
Immunohistochemistry
Paraffin blocks of embedded testicular tissue fixed in buffered formaldehyde. Bouin or Stieve solutions were derived from surgical biopsies of men with obstructive azoospermia selected for a normal pattern of germ cells in the testis tubules (kindly provided by M. Bergmann, Giessen). Tissue blocks were sectioned at 5 µm and mounted on SuperFrost Plus glass slides (Neolab, Heidelberg, Germany). After overnight storage at 37°C, sections were de-paraffinized with xylene (3x10 min) and re-hydrated with ethanolwater series. After washing for 3 min in permeabilization buffer (0.1 M Tris, 0.1 M NaCl, 0.1% Triton X-100; pH 7.4), the slides were incubated with 0.2 M boric acid, pH 7, at 60°C overnight. Standard avidinbiotin-complex (ABC) immunoperoxidase protocols (LINARIS, Wertheim, Germany, or Zymed, San Francisco, CA, USA) were used for staining the slides after incubation with the DBX-10 (1 : 100 v/v) and DBXY-20 (1 : 2000 v/v) antisera. Unspecific cross-reactions were blocked with 3% hydrogen peroxide in methanol, gentle shaking for 30 min at room temperature (RT). After pre-incubation of all slides in 3% goat serum (60 min at RT) incubation with the polyclonal antisera was performed overnight at 4°C in 1% goat serum. Slides (ABC treated) were stained with ACE (acetyl cabazole; Dako Cytomation, Glostrup, Denmark) or DAB (3,3'-diaminobenzidine tetrachloride : hydrogen peroxide; WAK Chemie, Steinbach, Germany) and subsequently counterstained with Gill's hematoxylin II (VWR International, Bruchsal, Germany) before mounting in Immu-Mount (Shandon, Pittsburgh, PA, USA).
| ACKNOWLEDGEMENTS |
|---|
We are indebted to Professor Martin Bergmann (University Giessen) for his generous and continuous support during the experimental phase of optimizing our immunohistochemical staining protocols and also training personally one of us (J.Z.). Hans Richard Rackwitz is thanked for his numerous experimental suggestions during preparation of the specific DBY and DBX peptides and antisera. The students Isabelle Dürk, Cornelia Kröger and Nina Rind are thanked for their experimental contributions to the comprehensive purification work of the crude DBY and DBX antisera and recombinant DBY and DBX proteins, respectively. Mrs Marie Luise Diarra and Prof. Peter Sinn (Section Gynecol. Pathology, University Women Hospital, Heidelberg, Germany) are thanked for their continuous support in preparing the testicular tissue sections and in the microscopic evaluation and imaging of the different immunohistochemical DBY and DBX staining patterns. This work was supported by a grant from the Deutsche Forschungsgemeinschaft to P.H.V. (DFG: Vo403/10-5).
| FOOTNOTES |
|---|
* To whom correspondence should be addressed at: Section of Molecular Genetics and Infertility, Department of Gynecological Endocrinology and Reproductive Medicine, University of Heidelberg, Voßstrasse 9, D-69115 Heidelberg, Germany. Tel: +49 6221567918; Fax: +49 62215633710; Email: peter_vogt{at}med.uni-heidelberg.de
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. ![]()
| REFERENCES |
|---|
|
|
|---|
-
Vogt, P.H., Edelmann, A., Kirsch, S., Henegariu, O., Hirschmann, P., Kiesewetter, F., Köhn, F.M., Schill, W.B., Farah, S., Ramos, C. et al. (1996) Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum. Mol. Genet., 5, 933945.
[Abstract/Free Full Text] -
Blanco, P., Shlumukova, M., Sargent, C.A., Jobling, M.A., Affara, N. and Hurles, M.E. (2000) Divergent outcomes of intrachromosomal recombination on the human Y chromosome: male infertility and recurrent polymorphism. J. Med. Genet. 37, 752758.
[Abstract/Free Full Text] -
Kamp, C., Hirschmann, P., Voss, H., Huellen, K. and Vogt, P.H. (2000) Two homologous retroviral sequence blocks in proximal Yq11 cause AZFa mircrodeletions as a result of intrachromosomal recombination events. Hum. Mol. Genet., 9, 25632572.
[Abstract/Free Full Text] -
Sun, C., Skaletsky, H., Rozen, S., Gromoli, J., Nieschlag, E., Oates R. and Page, D.C. (2000) Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum. Mol. Genet., 9, 22912296.
[Abstract/Free Full Text] -
Foresta, C., Ferlin, A., Garolla, A., Moro, E., Pistorello, M., Barbaux, S. and Rossato, M. (1998) High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum. Reprod., 13, 302307.
[Abstract/Free Full Text] - Kamp, C., Huellen, K., Fernandes, S., Sousa, M., Schlegel, P.N., Mielnik, A., Kleiman, S., Yavetz, H., Krause, W., Küpker, W., Johannisson, R. et al. (2001) High deletion frequency of the complete AZFa sequence occurs only in men with complete germ cell aplasia (Sertoli-cell-only-syndrome). Mol. Hum. Reprod., 10, 987994.
-
Vogt, P.H. (1998) Human chromosome deletions in Yq11, AZF candidate genes and male infertility: history and update. Mol. Hum. Reprod., 4, 739744.
[Abstract/Free Full Text] -
Sargent, C.A., Boucher, C.A., Kirsch, S., Brown, G., Weiss, B., Trundley, A., Burgoyne, P., Saut, N., Durand, C., Levy, N. and Terriou, P. (1999) The critical region of overlap defining the AZFa male infertility interval of proximal Yq contains three transcribed sequences. J. Med. Genet., 36, 670677.
[Abstract/Free Full Text] -
Jones, M.H., Furlong, R.A., Burkin, H., Chalmers, I.J., Brown, G.M., Khwaja, O. and Affara, N.A. (1996). The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum. Mol. Genet., 5, 16951701.
[Abstract/Free Full Text] -
Lahn, B.T. and Page, D.C. (1997) Functional coherence of the human Y chromosome. Science, 278, 675680.
[Abstract/Free Full Text] -
Park, S.H., Lee, S-G., Kim, Y. and Song, K. (1998) Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3
p11.23. Cytogenet. Cell Genet., 81, 178179.[CrossRef][Web of Science][Medline] - Chung, J., Lee, S-G. and Song, K. (1995) Identification of a human homolog of a putative RNA helicase gene (mDEAD3) expressed in mouse erythroid cells. Korean J. Biochem., 27, 193197.
- Abdelhaleem, M., Maltais, L. and Wain, H. (2003) The human DDX and DHX gene families of putative RNA helicases. Genomics, 81, 618622.[CrossRef][Web of Science][Medline]
-
Chuang, R.Y., Weaver, P.L., Liu, Z. and Chang, T.H. (1997) Requirement of the DEAD-box protein ded1p for messenger RNA translation. Science, 275, 14681471.
[Abstract/Free Full Text] -
Mamiya, N. and Worman, H.J. (1999) Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem., 274, 157511576.
[Abstract/Free Full Text] -
Fukumura, J., Noguchi, E., Sekiguchi, T. and Nishimoto, T. (2003) A temperature-sensitive mutant of the mammalian RNA helicase, DEAD-BOX X isoform, DBX, defective in the transition from G1 to S phase. J. Biochem., 134, 7182.
[Abstract/Free Full Text] - Sun, C., Skaletsky, H., Birren B., Devon, K., Tang, Z., Silber, S., Oates, R. and Page, D.C. (1999) An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y. Nature Genet., 23, 429432.[CrossRef][Web of Science][Medline]
-
Qureshi, S.J., Ross, A.R., Ma, K., Cooke, H.J., Intyre, M.A.M., Chandley, A.C. and Hargreave, T.B. (1996) Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically-determined spermatogenic failure in men. Mol. Hum. Reprod., 2, 775779.
[Abstract/Free Full Text] -
Foresta, C., Ferlin, A. and Moro, E. (2000) Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum. Mol. Genet., 9, 11611169.
[Abstract/Free Full Text] - Vogt, P.H. (2004) Molecular genetic of human male infertility: from genes to new therapeutic perspectives. Curr. Pharm. Des., 10, 471500.[CrossRef][Web of Science][Medline]
- Leroy, P., Alzari, P., Sassoon, D. and Wolgemuth, D. (1989) The protein encoded by a murine male germ cell-specific transcript is a putative ATP-dependent RNA helicase. Cell, 57, 549559.[CrossRef][Web of Science][Medline]
- Session, D.R., Lee, G.S. and Wolgemuth, D.J. (2001) Characterization of D1Pas1, a mouse autosomal homologue of the human AZFa region DBY, as a nuclear protein in spermatogenic cells. Fertil. Steril., 76, 804811.[CrossRef][Web of Science][Medline]
-
Gururajan, R., Mathews, L., Longo, F.J. and Weeks, D.L. (1994) An3 mRNA encodes an RNA helicase that colocalizes with nucleoli in Xenopus oocytes in a stage-specific manner. Proc. Natl Acad. Sci. USA, 91, 20562060.
[Abstract/Free Full Text] - Rogers, G.W., Komar, A.A. and Merrick, W.C. (2002) EIF4A: the godfather of the DEAD box helicases. Prog. Nucl. Acid. Res. Mol. Biol., 72, 307331.[Web of Science][Medline]
-
Rössler, O.G., Hloch, P., Schütz, N., Weitzenegger, T. and Stahl, H. (2000) Structure and expression of the human p68 RNA helicase gene. Nucl. Acids Res., 28, 932939.
[Abstract/Free Full Text] - Raz, E. (2000) The function and regulation of vasa-like genes in germ-cell development Genome Biol., 1, 1017.11017.6.
- Rocak, S. and Linder, P. (2004) DEAD-BOX proteins: the driving forces behind RNA metabolism. Nat. Rev. Cell Biol., 5, 232241.
- Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P.J., Cordum, H.S., Hillier, L., Brown, L.G., Repping, S., Pyntikova, T., Ali J., Bieri, T., Chinwalla, A. et al. (2003) The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature, 423, 825837.[CrossRef][Medline]
-
Mazeyrat, S., Saut, N., Sargent, C.A., Grimmond, S., Longepied, G., Ehrmann, I.E., Ellis, P.S., Greenfield, A., Affara, N.A. and Mitchell, M.J. (1998) The mouse Y chromosome interval necessary for spermatogonial proliferation is gene dense with syntenic homology to the human AZFa region. Hum. Mol. Genet., 7, 17131724.
[Abstract/Free Full Text] - Olsen, L.C., Aasland. R. and Fjose, A. (1997) A vasa-like gene in zebrafish identifies putative primordial germ cells. Mech. Dev., 66, 95105.[CrossRef][Web of Science][Medline]
-
Castrillon, D.H., Quade, B.J., Wang, T.Y., Quigley, C. and Crum, C.P. (2000) The human VASA gene is specifically expressed in the germ cell lineage. Proc. Natl Acad. Sci. USA, 97, 95859590.
[Abstract/Free Full Text] - Mazeyrat, S., Saut, N., Grigoriev, V., Mahadevaiah, S.K., Ojarikre, O.A., Rattigan, A., Bishop, C., Eicher, E.M., Mitchell, M.J. and Burgoyne, P.S. (2001) A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis. Nat. Genet., 29, 4953.[CrossRef][Web of Science][Medline]
- Wang, P.J. (2004) X chromosomes, retrogenes and their role in male reproduction. Trends Endocrinol. Metab., 15, 7983.[CrossRef][Web of Science][Medline]
- Fernandez-Capetillo, O., Mahadevaiah, K., Celeste, A., Romanienko, P.J., Camerino-Otero, R.D., Bonner, W.M., Manova, K., Burgoyne, P., Nussenzweig, A. (2003) H2AX is required for chromatin remodelling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell, 4, 497508.[CrossRef][Web of Science][Medline]
- Kim, Y-S., Lee, S-G., Park, S.H. and Song, K. (2001) Gene structure of the human DDX3 and chromosome mapping of its related sequences. Mol. Cell, 12, 206214.
-
Ehrmann, I.E., Ellis, P.E., Mazeyrat, S., Duthie, S., Brockdorff, N., Mattai, M.G., Gavin, M.A., Affara, N.A., Brown, G.M., Simpson, E., Mitchell, M.J. and Scott, D.M. (1998) Characterization of genes encoding translation initiation factor eIF-2
in mouse and human: sex chromosome localization, escape from X-inactivation and evolution. Hum. Mol. Genet., 7, 17251737.[Abstract/Free Full Text] - Sutcliffe, M.J. and Burgoyne, P.S. (1989) Analysis of the testis of HY negative X0Sxrb mice suggests that the spermatogenesis gene (Spy) acts during differentiation of the A spermatogonia. Development, 107, 373380.[Abstract]
-
Murphy, W.J., Sun, S., Cheen, Z.-Q., Pecon-Slattery, J. and O'Brien, S.J. (1999) Extensive conservation of sex chromosome organization between cat and human revealed by parallel radiation hybrid mapping. Genome Res., 9, 12231230.
[Abstract/Free Full Text] - Quilter, C.R., Blott, S.C., Mileham, A.J., Affara, N.A., Sargent, C.A. and Griffin, D.K. (2002) A mapping and evolutionary study of porcine sex chromosome genes. Mamm. Genome, 13, 588594.[CrossRef][Web of Science][Medline]
-
Wilkie, A.O. (1994) The molecular genetic dominance. J. Med. Genet., 31, 8998.
[Abstract/Free Full Text] - Krausz, C., Forti, G. and McElreavey, K. (2003) The Y chromosome and male fertility and infertility. Int. J. Androl., 26, 7075.[CrossRef][Web of Science][Medline]
-
Pardigol, A., Magert, H.J., Hill, O. and Forssmann, W.G. (1996) Functional analysis of the human guanylin gene promoter. Biochem. Biophys. Res. Commun., 224, 638644.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
A. Luddi, M. Margollicci, L. Gambera, F. Serafini, M. Cioni, V. De Leo, P. Balestri, and P. Piomboni Spermatogenesis in a Man with Complete Deletion of USP9Y N. Engl. J. Med., February 26, 2009; 360(9): 881 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Lardone, D.A. Parodi, R. Valdevenito, M. Ebensperger, A. Piottante, M. Madariaga, R. Smith, R. Pommer, N. Zambrano, and A. Castro Quantification of DDX3Y, RBMY1, DAZ and TSPY mRNAs in testes of patients with severe impairment of spermatogenesis Mol. Hum. Reprod., October 1, 2007; 13(10): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.E. Kleiman, L. Yogev, R. Hauser, A. Botchan, B.B.-S. Maymon, G. Paz, and H. Yavetz Expression profile of AZF genes in testicular biopsies of azoospermic men Hum. Reprod., January 1, 2007; 22(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Krausz, S. Degl'Innocenti, F. Nuti, A. Morelli, F. Felici, M. Sansone, G. Varriale, and G. Forti Natural transmission of USP9Y gene mutations: a new perspective on the role of AZFa genes in male fertility Hum. Mol. Genet., September 15, 2006; 15(18): 2673 - 2681. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Linder Dead-box proteins: a family affair--active and passive players in RNP-remodeling Nucleic Acids Res., September 10, 2006; 34(15): 4168 - 4180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. P. Vong, Y. Li, Y.-F. C. Lau, M. Dym, O. M. Rennert, and W.-Y. Chan Structural Characterization and Expression Studies of Dby and Its Homologs in the Mouse J Androl, September 1, 2006; 27(5): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kim, D. J. Dix, K. E. Thompson, R. N. Murrell, J. E. Schmid, J. E. Gallagher, and J. C. Rockett Gene expression in head hair follicles plucked from men and women. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 115 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Vogt AZF deletions and Y chromosomal haplogroups: history and update based on sequence Hum. Reprod. Update, July 1, 2005; 11(4): 319 - 336. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||










